Search Results

Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control.

• Authors : Lima L; Program in Cell and Developmental Biology, Institute for Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Berni M

• Source: The CRISPR journal [CRISPR J] 2024 Apr 01. Date of Electronic Publication: 2024 Apr 01.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.

• Authors : Molugu K; Biophysics Graduate Program, University of Wisconsin-Madison, Madison, Wisconsin, USA; St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Induced Pluripotent Stem Cells*; Humans

• Source: The CRISPR journal [CRISPR J] 2023 Oct; Vol. 6 (5), pp. 473-485. Date of Electronic Publication: 2023 Sep 07.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering.

• Authors : Lamothe RC; Metagenomi, Inc., Emeryville, California, USA.; Storlie MD

Subjects: Gene Editing* ; CRISPR-Cas Systems*/CRISPR-Cas Systems*/CRISPR-Cas Systems*/genetics; Humans

• Source: The CRISPR journal [CRISPR J] 2023 Jun; Vol. 6 (3), pp. 243-260. Date of Electronic Publication: 2023 May 23.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

T Cell Nrf2/Keap1 Gene Editing Using CRISPR/Cas9 and Experimental Kidney Ischemia-Reperfusion Injury.

• Authors : Kurzhagen JT; Division of Nephrology and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Noel S

Subjects: Antioxidants*/Antioxidants*/Antioxidants*/metabolism ; Reperfusion Injury*/Reperfusion Injury*/Reperfusion Injury*/genetics ; Reperfusion Injury*/Reperfusion Injury*/Reperfusion Injury*/therapy

• Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 May; Vol. 38 (13-15), pp. 959-973. Date of Electronic Publication: 2023 Mar 16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient.

• Authors : Leclerc D; INSERM U1242, OSS, Univ Rennes, Rennes, France.; Goujon L

Subjects: Gangliosidosis, GM1*/Gangliosidosis, GM1*/Gangliosidosis, GM1*/therapy ; Gangliosidosis, GM1*/Gangliosidosis, GM1*/Gangliosidosis, GM1*/drug therapy; Humans

• Source: The CRISPR journal [CRISPR J] 2023 Feb; Vol. 6 (1), pp. 17-31. Date of Electronic Publication: 2023 Jan 11.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Optimized Guide RNA Selection Improves Streptococcus pyogenes Cas9 Gene Editing of Human Hematopoietic Stem and Progenitor Cells.

• Authors : Verhagen HJMP; Department of Hematopoiesis and Sanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, The Netherlands.; Kuijk C

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods; Humans ; CRISPR-Cas Systems/CRISPR-Cas Systems/CRISPR-Cas Systems/genetics

• Source: The CRISPR journal [CRISPR J] 2022 Oct; Vol. 5 (5), pp. 702-716. Date of Electronic Publication: 2022 Sep 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Gene Editing and Rett Syndrome: Does It Make the Cut?

• Authors : Coorey B; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, Australia; Military Institute of Medicine, Warsaw, Poland.

Subjects: Rett Syndrome*/Rett Syndrome*/Rett Syndrome*/genetics ; Rett Syndrome*/Rett Syndrome*/Rett Syndrome*/metabolism ; Rett Syndrome*/Rett Syndrome*/Rett Syndrome*/therapy

• Source: The CRISPR journal [CRISPR J] 2022 Aug; Vol. 5 (4), pp. 490-499. Date of Electronic Publication: 2022 Jul 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.

• Authors : Rathbone T; Department of Bioengineering, University College Cork, Cork, Ireland.; Ates I

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Ribonucleoproteins*/Ribonucleoproteins*/Ribonucleoproteins*/genetics ; Ribonucleoproteins*/Ribonucleoproteins*/Ribonucleoproteins*/metabolism

• Source: The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 397-409. Date of Electronic Publication: 2022 Mar 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes.

• Authors : Sanchez-Baltasar R; Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Zygote*/Zygote*/Zygote*/metabolism; Animals

• Source: The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 422-434.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details

Gene Editing of Checkpoint Molecules in Cord Blood-Derived Dendritic Cells and CD8 + T Cells Using CRISPR-Cas9.

• Authors : Lo Presti V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.

Subjects: Gene Editing*/Gene Editing*/Gene Editing*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/genetics; CD8-Positive T-Lymphocytes

• Source: The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 435-444.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print Cited

Record details